Trial intelligence / Profile preview

Ketamine as co-analgesic for tumor-related pain (Phase II)

2006-006244-58Phase 2Completed

Sponsor
LKH-Universitätsklinikum Graz
Start
Feb 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of ketamine in pain and cancer pain, sponsored by LKH-Universitätsklinikum Graz. Primary endpoint: Improvement in pain therapy in tumor patients. Started Feb 2007; status: completed.

02

Drugs

ketamine
03

Conditions

paincancer pain

Beyond the preview

Go deeper on 2006-006244-58.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006244-58.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call